Global Peritoneal Dialysis Market

Peritoneal Dialysis Market Size, Share, Growth Analysis, By Product Type(CAPD, APD), By Product(Cyclers, Fluids), By End User(Home Health Care, Hospitals), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2183 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 87 | Figures: 77

Peritoneal Dialysis Market News

  • In June 2022, the increasing range of Radio Frequency Technology (RIFD) from Fresenius, a world leader in the provision of dialysis solutions, is now compatible with AmerisourceBergen's Medication Tray solution, according to an announcement made, which is one of the largest pharmaceutical wholesalers in the US and a worldwide healthcare organization. The purpose of this medicine tray solution is to increase hospital drug inventory visibility.
  • In May 2022, the Food and Drug Administration (FDA) granted permission to the portable automated peritoneal dialysis system known as the "PD Cycler System," according to Fresenius Medical Care, the world's largest provider of goods and services for people with renal illness. As the market leader in renal care products in the US, Fresenius is developing cutting-edge technologies to boost the development of at-home treatments by upgrading home dialysis equipment.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Peritoneal Dialysis Market size was valued at USD 76.9 billion in 2019 and is poised to grow from USD 81.8 billion in 2023 to USD 126.43 billion by 2031, growing at a CAGR of 6.4% in the forecast period (2024-2031).

The peritoneal dialysis market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. For example, to enhance the patient treatment experience and for better overall results, Medtronic, a pioneer in healthcare technology, has partnered with DaVita's extensive experience as a provider of comprehensive kidney care. Together, they plan to establish a new independent medical device company called "NewCo," with a focus on kidneys. For patients with renal failure, NewCo will be positioned as an advanced firm of discovery and distinctive therapeutics. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions. ' Baxter B. Braun Melsungen AG Fresenius Medical Care AG & Co. KGaA Medtronic plc Terumo Corporation Cook Medical Inc. Utah Medical Products Inc. Cardinal Health Inc. Poly Medicure Limited Diversified Specialty Institute Holdings Inc. Renax Biomedical Tech Co. Ltd. Renal Solutions Inc. Vygon SA Merit Medical Systems Inc. Huaren Pharmaceutical Co. Ltd. Nikkiso Co. Ltd. Nephros Inc. Covidien plc AngioDynamics Inc. Q Core Medical Ltd. ', 'Baxter', 'B. Braun Melsungen AG', 'Fresenius Medical Care AG & Co. KGaA', 'Medtronic plc', 'Terumo Corporation', 'Cook Medical Inc.', 'Utah Medical Products Inc.', 'Cardinal Health Inc.', 'Poly Medicure Limited', 'Diversified Specialty Institute Holdings Inc.', 'Renax Biomedical Tech Co. Ltd.', 'Renal Solutions Inc.', 'Vygon SA', 'Merit Medical Systems Inc.', 'Huaren Pharmaceutical Co. Ltd.', 'Nikkiso Co. Ltd.', 'Nephros Inc.', 'Covidien plc', 'AngioDynamics Inc.', 'Q Core Medical Ltd.'

During the projected period, factors like rising end-stage renal disease (ESRD) prevalence, technical advancements in peritoneal dialysis cyclers, and rising demand for home dialysis treatment is anticipated to propel the growth of the peritoneal dialysis market. Peritoneal dialysis also has several benefits, including lower costs compared to hemodialysis, needle-free therapy, mobility, ease of treatment, and fewer dietary restrictions, which all contribute to the market's expansion internationally.

The primary growth drivers of the peritoneal dialysis market are increase in the prevalence of End Stage Renal Disease (ESRD), increase in the number of patients with acute diabetes and high blood pressure, increased public awareness of peritoneal dialysis, increased government initiatives globally, and an increase in the demand for technologically advanced treatment methods. Additionally, growing peritoneal dialysis use in developing nations like China, India, and others would open up new prospects for the peritoneal dialysis market.

With a market share of more than 35.0 percent and the highest revenue in 2021, North America dominated the peritoneal dialysis market. The region's market is expanding as a result of the existence of important players, large government expenditures in the creation of cutting-edge medical devices, and a favorable reimbursement environment. Dialysis is becoming more popular as a result of the increase in kidney failures and chronic kidney diseases (CKD). High disposable income, government efforts, and rising healthcare spending are a few major reasons boosting the industry.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Peritoneal Dialysis Market

Report ID: SQMIG35D2183

$5,300
BUY NOW GET FREE SAMPLE